---
figid: PMC10042294__fcell-11-1086964-g007
figtitle: Dark side of mRNA translation and the translation machinery in glioblastoma
organisms:
- Saccharomyces cerevisiae
- Aglaia silvestris
- Homo sapiens
- Mus musculus
- Danio rerio
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC10042294
filename: fcell-11-1086964-g007.jpg
figlink: /pmc/articles/PMC10042294/figure/F7/
number: F7
caption: Chemical compounds targeting translation in GB. (A) Drugs targeting the eIF4E/eIF4G
  complex ( Left ) and the MAPK/ERK/p38/Mnk1 pathway ( Right ). (B) Drugs targeting
  the PI3K/AKT/mTOR pathway. (C) Silvestrol inhibits the eIF4A (4A) activity. (D)
  Compounds blocking the interaction between the hnRNP A1 protein with the Cyclin
  D1 and c-Myc IRES, thereby inhibiting IRES-dependent mRNA translation. (E) Quinupristin
  and Dalfopristin (Q/D) act synergistically to inhibit mitochondrial protein synthesis.
  These drugs bind to the mitoribosomal large subunit (green). MOM, mitochondrial
  outer membrane; IMS, Inter membrane space; MIM, Mitochondrial inner membrane; MM,
  mitochondrial matrix. Solid lines indicate a direct effect of the inhibitors on
  the translation machinery. Dashed lines indicate that the effect is not direct on
  the translation apparatus, but rather to the signaling cascades.
papertitle: The dark side of mRNA translation and the translation machinery in glioblastoma.
reftext: Angélica Montiel-Dávalos, et al. Front Cell Dev Biol. 2023;11:1086964.
year: '2023'
doi: 10.3389/fcell.2023.1086964
journal_title: Frontiers in Cell and Developmental Biology
journal_nlm_ta: Front Cell Dev Biol
publisher_name: Frontiers Media S.A.
keywords: cancer | translation initiation | glioblastoma | ribosomal proteins (RP)
  | eIF4E | translation machinery | TMZ (temozolomide)
automl_pathway: 0.8098165
figid_alias: PMC10042294__F7
figtype: Figure
redirect_from: /figures/PMC10042294__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10042294__fcell-11-1086964-g007.html
  '@type': Dataset
  description: Chemical compounds targeting translation in GB. (A) Drugs targeting
    the eIF4E/eIF4G complex ( Left ) and the MAPK/ERK/p38/Mnk1 pathway ( Right ).
    (B) Drugs targeting the PI3K/AKT/mTOR pathway. (C) Silvestrol inhibits the eIF4A
    (4A) activity. (D) Compounds blocking the interaction between the hnRNP A1 protein
    with the Cyclin D1 and c-Myc IRES, thereby inhibiting IRES-dependent mRNA translation.
    (E) Quinupristin and Dalfopristin (Q/D) act synergistically to inhibit mitochondrial
    protein synthesis. These drugs bind to the mitoribosomal large subunit (green).
    MOM, mitochondrial outer membrane; IMS, Inter membrane space; MIM, Mitochondrial
    inner membrane; MM, mitochondrial matrix. Solid lines indicate a direct effect
    of the inhibitors on the translation machinery. Dashed lines indicate that the
    effect is not direct on the translation apparatus, but rather to the signaling
    cascades.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - oh
  - Pik3r1
  - Akt1
  - Mtor
  - Mtss1
  - Polr3k
  - Pip4k2b
  - Ephb2
  - Mapk1
  - Mknk1
  - Mapk3
  - Mknk2
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Hnrnph2
  - Hnrnpa1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - MTSS1
  - AKR1C4
  - GZMB
  - POLR3K
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - MKNK1
  - MKNK2
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - ADRA1D
  - HNRNPC
  - HNRNPDL
  - HNRNPA1
  - E(spl)mgamma-HLH
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Tor
  - Thor
  - dome
  - mim
  - Hn
  - coq
  - MKP-4
  - p38b
  - rl
  - Erk7
  - lic
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - Col4a1
  - Ca-alpha1D
  - alphaTub84B
  - nAChRalpha1
  - wb
  - Prosalpha1
---
